www.uhasselt.be
DSpace

Document Server@UHasselt >
Research >
All items >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/10020

Title: Innovation for growth in mature industries: Solvay's influenza business
Authors: Poot, Tom
Faems, Dries
VANHAVERBEKE, Wim
Issue Date: 2009
Publisher: World Scientific Publishing Co. Pte. Ltd
Citation: International Journal of Innovation Management, 13(2). p. 1-14
Abstract: Purpose – Major technological innovations are usually associated with central R&D facilities in large companies and leading edge technologies that are key to unlocking business opportunities in promising, embryonic markets. The purpose of this paper is to identify and analyze several factors that determine the success of a major process innovation in a mature but changing industry. The paper furthermore shows that the periphery of a company can be as innovative as headquarters and central R&D-labs. Design/methodology/approach – This paper is based upon an in depth case study of the “Business Group Influenza” (BGI) at Solvay, a multinational company in the chemical and pharmaceutical industry based in Brussels. BGI turned a mature business into a growth engine for the company through the development of a cell culture technology. Next, we identified 20 success factors of innovations based on extensive literature research. These factors can be placed in four main categories; strategic factors, market environment factors, development process factors, and organizational factors. In this paper, we apply these key drivers to the renewal of Solvay's influenza vaccine business. Findings – It is found that a systematic analysis of the case using the 20 key drivers allows us to evaluate the management of this major innovation process. In this way, one can easily spot the drivers that need more attention or require another management approach. We also find that the management of attention of the top-management is crucial in long-term innovation projects. Originality/value – The contribution of this study is twofold. On the one hand, the rejuvenation of Solvay's influenza vaccine business shows that changing markets conditions in combination with a breakthrough process technology can turn a cash cow into a growth business. On the other hand, the systematic analysis of key innovation drivers allows one to identify the strength and weaknesses in the management of a long-term, breakthrough process innovation
URI: http://hdl.handle.net/1942/10020
DOI: 10.1108/17561410910949382
ISSN: 1363-9196
Category: A1
Type: Journal Contribution
Validation: vabb, 2010
Appears in Collections: Innovation Management
Strategy and Organisation - Archive

Files in This Item:

There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.